The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis.
The Effect of High-intensity Intermittent Exercise and Moderate-intensity Continuous Exercise on Serum Irisin Levels, Disease Activity, Functional Status, and Quality of Life in Patients With Axial Spondyloarthritis: a Prospective, Randomized Study
1 other identifier
interventional
75
1 country
1
Brief Summary
This study aimed to investigate the effects of high-intensity intermittent exercise and moderate-intensity continuous exercise on serum irisin levels, disease activity, functional status, and quality of life in patients with axial spondyloarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedJanuary 12, 2026
December 1, 2025
3 months
December 25, 2025
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum irisin level
Blood samples will be taken from patients one day before the start of treatment, after a 12-hour fast, and again the morning after a 12-hour fast, immediately after the end of treatment. The collected blood samples will be centrifuged at 1500 g for 10 minutes to obtain serum. The obtained serum will be stored at -80°C until the day of the study. The aim of these serum samples is to determine the level of irisin.
Before treatment and after treatment (week 8)
Secondary Outcomes (5)
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Before treatment, after treatment (week 8)
Ankylosing Spondylitis Activity Scoring-CRP (ASDAS-CRP)
Before treatment, after treatment (week 8)
Bath Ankylosing Spondylitis Functional Index (BASFI)
Before treatment, after treatment (week 8)
Bath Ankylosing Spondylitis Metrology Index (BASMI)
Before treatment, after treatment (week 8)
Ankylosing Spondylitis Quality of Life Scale (ASQoL)
Before treatment, after treatment (week 8)
Study Arms (3)
high-intensity exercise
EXPERIMENTALPatients in this group will receive information and education about their condition and will be instructed to continue their current medical treatment and attend follow-up appointments regularly. Additionally, this group will undergo a high-intensity interval training (HIIT) program with a physiotherapist for 40 sessions in total, 5 sessions per week for 8 weeks, each lasting 35 minutes. Patients will work at 80% to 100% of their maximum heart rate. The first 4 weeks will be at 80% of maximum heart rate, followed by 85%, 90%, 95%, and finally 100%. This protocol will consist of 4 active periods of 4 minutes each at 80% to 100% of maximum heart rate (percentage to be determined weekly) and 3 rest periods of 3 minutes each at 60-70% of maximum heart rate (4x4 minutes). Each session will include a 5-minute warm-up before HIIT and a 5-minute cool-down after HIIT, for a total exercise time of 35 minutes.
moderate intensity exercise
EXPERIMENTALPatients in this group will receive information and education about their condition and will be instructed to continue their current medical treatment and attend regular follow-up appointments. Additionally, these patients will undergo a 40-minute, 5-session, 40-minute moderate-intensity continuous exercise (MCIT) program with a physiotherapist over 8 weeks. Patients will exercise at 50-70% of their maximum heart rate and with an RPE of 11-13 for 30 minutes. Each session will include a 5-minute warm-up before MCIT and a 5-minute cool-down after MCIT, for a total exercise duration of 40 minutes.
control
ACTIVE COMPARATORPatients in this group will receive information and education about their illness and will be advised to continue their current medical treatment and attend their follow-up appointments regularly.
Interventions
Patients will be trained at 80% to 100% of their maximum heart rate. For the first 4 weeks, they will train at 80% of their maximum heart rate, then at 85%, 90%, 95%, and finally 100%. This protocol will consist of 4 active periods of 4 minutes each at 80% to 100% of maximum heart rate (percentage to be determined weekly) and 3 rest periods of 3 minutes each at 60-70% of maximum heart rate (4x4 minutes). Each session will include a 5-minute warm-up before HIIT and a 5-minute cool-down after HIIT, for a total exercise time of 35 minutes.
Patients will be trained for 30 minutes at 50% to 70% of their maximum heart rate and with an RPE of 11-13. Each session will include a 5-minute warm-up before MCIT and a 5-minute cool-down after MCIT, for a total exercise time of 40 minutes.
They will be given information and education about their illnesses and will be advised to continue their current medical treatment and attend their follow-up appointments regularly.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with axillary spondyloarthropathy according to ASAS diagnostic criteria,
- Having a high disease severity (ASDAS-CRP above 2.1),
- Being sedentary (not engaging in physical activity at least 3 days a week in the last 3 months),
- Having no change in ankylosing spondylitis medical treatment in the last 3 months,
- Not having any orthopedic, neurological, cardiovascular, or mental disease that would affect exercise,
- Not using any assistive devices for ambulation,
- Having a BMI of 25 kg/m2 or less,
- Male and female patients aged 18-50 years.
You may not qualify if:
- Those with uncontrolled cardiopulmonary disease (such as hypertension, chronic obstructive pulmonary disease, heart failure),
- Having comorbidities that reduce exercise capacity,
- Pregnancy,
- Malignancy,
- Those with a recent history of surgery,
- Those who have engaged in regular exercise (aquatic exercise, land exercise, etc.) in the previous 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kirsehir Ahi Evran Universitesilead
- Scientific Research Projectscollaborator
Study Sites (1)
Kırşehir Ahi Evran Üniversitesi
Kırşehir, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
December 25, 2025
First Posted
January 8, 2026
Study Start
January 30, 2026
Primary Completion
April 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
January 12, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share